{"id":"W2606334551","doi":"10.1002/cpdd.358","title":"Single‐ and Multiple‐Dose Pharmacokinetics of Once‐Daily Formulations of Raltegravir","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Raltegravir; Pharmacokinetics; Bioavailability; Pharmacology; Medicine; Biopharmaceutics; Dosing; Biopharmaceutics Classification System; In vivo; Human immunodeficiency virus (HIV); Chemistry; Virology; Antiretroviral therapy; In vitro; Biological activity; Biology; Viral load; Biochemistry; Pharmacognosy; Biotechnology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575608,0.0002020676,0.0007429885,0.0002133523,0.000116361,0.0003879494,0.0002554237,0.0003341715,0.001259532],"category_scores_gemma":[0.001021953,0.0002239572,0.0002673597,0.0001780917,0.0001557866,0.0004306888,0.0000872899,0.0008350306,0.0002553914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002518448,"about_ca_system_score_gemma":0.000308311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005040284,"about_ca_topic_score_gemma":0.0004866758,"domain_scores_codex":[0.999713,0.00009372795,0.00001565536,0.00005604694,0.0000978808,0.00002372953],"domain_scores_gemma":[0.9996938,0.00008699556,0.00006449781,0.00004087534,0.00004450478,0.00006944263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03274024,0.004253686,0.004773112,0.0001953858,0.0001793887,0.0001423816,0.0002179438,0.001538613,0.825843,0.0002561077,0.000907502,0.1289527],"study_design_scores_gemma":[0.008979698,0.2015217,0.1510135,0.0000619421,0.0005019543,0.002929535,0.0001688422,0.04228984,0.5801092,0.0005133401,0.01174082,0.000169696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962987,0.0009495897,0.001798621,0.00003277257,0.00002962094,0.0000912887,0.0002074052,0.00008208108,0.0005100318],"genre_scores_gemma":[0.9954305,0.0003893125,0.002753507,0.00004297253,0.00002061247,0.0000988826,0.0003757913,0.0000295099,0.00085891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001259532,"threshold_uncertainty_score":0.004213572,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08495309511939617,"score_gpt":0.4174303690147653,"score_spread":0.3324772738953691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}